Aprepitant Injection 18 mL: 130 mg
When used in combination with other antiemetic agents, this product is indicated for the prevention of acute and delayed nausea and vomiting in adult patients undergoing: 1) initial and repeat courses of highly emetogenic chemotherapy (HEC); and 2) delayed nausea and vomiting during initial and repeat courses of moderately emetogenic chemotherapy (MEC).
Aprepitant Injection 18 mL: 130 mg
- Description
-
When used in combination with other antiemetic agents, this product is indicated for the prevention of acute and delayed nausea and vomiting in adult patients undergoing: 1) initial and repeat courses of highly emetogenic chemotherapy (HEC); and 2) delayed nausea and vomiting during initial and repeat courses of moderately emetogenic chemotherapy (MEC).
Related Products
Online Message
If you have any suggestions, please leave a message or send us an email. We’ll reply to you as soon as possible after receiving your message or email.
Address: 6th Floor, Building C6, Jiangsu Life Science and Technology Innovation Park, Qixia District, Nanjing City
Official account